Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference36 articles.
1. Global and regional patterns in cardiovascular mortality from 1990 to 2013;Roth;Circulation,2015
2. Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort;Ademi;Cardiovasc. Ther.,2013
3. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis;Bhatt;JAMA,2006
4. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
5. Apixaban in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2011
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective;American Journal of Cardiovascular Drugs;2023-12-28
2. Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis;BMJ Open;2023-04
3. Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis;American Journal of Cardiovascular Drugs;2023-03-03
4. The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial;European Heart Journal - Quality of Care and Clinical Outcomes;2022-08-24
5. Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease;Frontiers in Pharmacology;2022-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3